Lupin Pharmaceuticals Recalls All Irbesartan Tablets and Irbesartan & Hydrochlorothiazide Tablets Due to the Presence of N-nitrosoirbesartan, a Known Human Carcinogen WASHINGTON, D.C. - On October 14, 2021, the U.S. Food and Drug Administration announced Lupin Pharmaceuticals, Inc. had initiated a recall of its  Irbesartan … [Read more...] about Irbesartan and Irbesartan plus Hydrochlorothiazide Recalls